Language:
English
繁體中文
Help
Login
Back
Switch To:
Labeled
|
MARC Mode
|
ISBD
Theranostics Approaches to Gastric a...
~
Bhaskar, L.V.K.S.
Theranostics Approaches to Gastric and Colon Cancer
Record Type:
Language materials, printed : Monograph/item
Title/Author:
Theranostics Approaches to Gastric and Colon Cancer/ edited by Ganji Seeta Rama Raju, L.V.K.S. Bhaskar.
other author:
Raju, Ganji Seeta Rama.
Description:
XIII, 250 p. 26 illus., 17 illus. in color.online resource. :
Contained By:
Springer Nature eBook
Subject:
Cancer research. -
Online resource:
https://doi.org/10.1007/978-981-15-2017-4
ISBN:
9789811520174
Theranostics Approaches to Gastric and Colon Cancer
Theranostics Approaches to Gastric and Colon Cancer
[electronic resource] /edited by Ganji Seeta Rama Raju, L.V.K.S. Bhaskar. - 1st ed. 2020. - XIII, 250 p. 26 illus., 17 illus. in color.online resource. - Diagnostics and Therapeutic Advances in GI Malignancies,2662-2688. - Diagnostics and Therapeutic Advances in GI Malignancies,.
Chapter 1. Therapeutic role of Phytochemicals in Colorectal cancer -- Chapter 2. Adiponectin Signaling In Colorectal Cancer -- Chapter 3. Role of Matrix Metalloproteinases in Colorectal Cancer -- Chapter 4. The Role of Hypoxia-Inducible Factor 1- Alpha in Colorectal Cancer -- Chapter 5. Mechanisms and pathways of metabolic reprogramming of colorectal cancer -- Chapter 6. Targeting metabolic reprogramming of colorectal cancer -- Chapter 7. Understanding colorectal cancer: the basics -- Chapter 8. Molecular signaling pathways involved in gastric cancer chemoresistance -- Chapter 9. Meta-analysis reveals no significant association of EPHX1 Tyr113His and His139Arg polymorphisms with the colorectal cancer risk -- Chapter 10. Meta-analysis of genetic variants in alcohol metabolizing enzymes and their association with colorectal cancer risk -- Chapter 11. Gut microbiota as signatures in non-communicable diseases and mucosal immunity -- Chapter 12. Immunotherapy for Colon Cancer: Recent Perspectives -- Chapter 13. Nanotechnology Applications in Gastric cancer. .
This book highlights the importance of understanding gastric and colon cancer metabolism in guiding diagnosis and drug discovery. It summarizes the correlation between adiponectin and matrix metalloproteinase with colorectal cancer. The book also evaluates the divergent role of hypoxia-inducible factor 1 in colorectal cancer growth and metastasis. After discussing the role of genetic polymorphisms in alcohol metabolizing enzymes and EPHX1 with the onset of colorectal cancer, it reviews the molecular mechanisms of chemoresistance in gastric cancer and novel therapeutic strategies to reverse the chemoresistance of tumors. In addition, the book explores the theranostic role of nanoparticles and therapeutic potential of phytochemicals with regard to colorectal cancer. Given its scope, the book offers a valuable guide for oncologists, academic researchers, pharmaceuticals practitioners, and students who are involved in research and treatment of cancer.
ISBN: 9789811520174
Standard No.: 10.1007/978-981-15-2017-4doiSubjects--Topical Terms:
1253664
Cancer research.
LC Class. No.: RC261-271
Dewey Class. No.: 614.5999
Theranostics Approaches to Gastric and Colon Cancer
LDR
:03505nam a22004095i 4500
001
1019578
003
DE-He213
005
20200701101212.0
007
cr nn 008mamaa
008
210318s2020 si | s |||| 0|eng d
020
$a
9789811520174
$9
978-981-15-2017-4
024
7
$a
10.1007/978-981-15-2017-4
$2
doi
035
$a
978-981-15-2017-4
050
4
$a
RC261-271
072
7
$a
MJCL
$2
bicssc
072
7
$a
MED062000
$2
bisacsh
072
7
$a
MJCL
$2
thema
082
0 4
$a
614.5999
$2
23
245
1 0
$a
Theranostics Approaches to Gastric and Colon Cancer
$h
[electronic resource] /
$c
edited by Ganji Seeta Rama Raju, L.V.K.S. Bhaskar.
250
$a
1st ed. 2020.
264
1
$a
Singapore :
$b
Springer Singapore :
$b
Imprint: Springer,
$c
2020.
300
$a
XIII, 250 p. 26 illus., 17 illus. in color.
$b
online resource.
336
$a
text
$b
txt
$2
rdacontent
337
$a
computer
$b
c
$2
rdamedia
338
$a
online resource
$b
cr
$2
rdacarrier
347
$a
text file
$b
PDF
$2
rda
490
1
$a
Diagnostics and Therapeutic Advances in GI Malignancies,
$x
2662-2688
505
0
$a
Chapter 1. Therapeutic role of Phytochemicals in Colorectal cancer -- Chapter 2. Adiponectin Signaling In Colorectal Cancer -- Chapter 3. Role of Matrix Metalloproteinases in Colorectal Cancer -- Chapter 4. The Role of Hypoxia-Inducible Factor 1- Alpha in Colorectal Cancer -- Chapter 5. Mechanisms and pathways of metabolic reprogramming of colorectal cancer -- Chapter 6. Targeting metabolic reprogramming of colorectal cancer -- Chapter 7. Understanding colorectal cancer: the basics -- Chapter 8. Molecular signaling pathways involved in gastric cancer chemoresistance -- Chapter 9. Meta-analysis reveals no significant association of EPHX1 Tyr113His and His139Arg polymorphisms with the colorectal cancer risk -- Chapter 10. Meta-analysis of genetic variants in alcohol metabolizing enzymes and their association with colorectal cancer risk -- Chapter 11. Gut microbiota as signatures in non-communicable diseases and mucosal immunity -- Chapter 12. Immunotherapy for Colon Cancer: Recent Perspectives -- Chapter 13. Nanotechnology Applications in Gastric cancer. .
520
$a
This book highlights the importance of understanding gastric and colon cancer metabolism in guiding diagnosis and drug discovery. It summarizes the correlation between adiponectin and matrix metalloproteinase with colorectal cancer. The book also evaluates the divergent role of hypoxia-inducible factor 1 in colorectal cancer growth and metastasis. After discussing the role of genetic polymorphisms in alcohol metabolizing enzymes and EPHX1 with the onset of colorectal cancer, it reviews the molecular mechanisms of chemoresistance in gastric cancer and novel therapeutic strategies to reverse the chemoresistance of tumors. In addition, the book explores the theranostic role of nanoparticles and therapeutic potential of phytochemicals with regard to colorectal cancer. Given its scope, the book offers a valuable guide for oncologists, academic researchers, pharmaceuticals practitioners, and students who are involved in research and treatment of cancer.
650
0
$a
Cancer research.
$3
1253664
650
0
$a
Gastroenterology .
$3
1254565
650
0
$a
Oncology .
$3
1253469
650
0
$a
Genetics.
$3
578972
650
1 4
$a
Cancer Research.
$3
668358
650
2 4
$a
Gastroenterology.
$3
673684
650
2 4
$a
Oncology.
$3
593951
650
2 4
$a
Genetics and Genomics.
$3
1229010
700
1
$a
Raju, Ganji Seeta Rama.
$e
editor.
$4
edt
$4
http://id.loc.gov/vocabulary/relators/edt
$3
1314889
700
1
$a
Bhaskar, L.V.K.S.
$e
editor.
$4
edt
$4
http://id.loc.gov/vocabulary/relators/edt
$3
1314890
710
2
$a
SpringerLink (Online service)
$3
593884
773
0
$t
Springer Nature eBook
776
0 8
$i
Printed edition:
$z
9789811520167
776
0 8
$i
Printed edition:
$z
9789811520181
776
0 8
$i
Printed edition:
$z
9789811520198
830
0
$a
Diagnostics and Therapeutic Advances in GI Malignancies,
$x
2662-2688
$3
1314891
856
4 0
$u
https://doi.org/10.1007/978-981-15-2017-4
912
$a
ZDB-2-SBL
912
$a
ZDB-2-SXB
950
$a
Biomedical and Life Sciences (SpringerNature-11642)
950
$a
Biomedical and Life Sciences (R0) (SpringerNature-43708)
based on 0 review(s)
Multimedia
Reviews
Add a review
and share your thoughts with other readers
Export
pickup library
Processing
...
Change password
Login